Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....

228/LG/SE/AUG/2026/GBSL August 10, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 509079 Scrip Symbol: GUFICBIO Subject: Intimation of Board Meeting of the Company Dear Sir/Madam, Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 14, 2026, inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended June 30, 2026. Further in continuation to our disclosure on the Closure of Trading Window dated June 26, 2026 and pursuant to the Company’s Code of Conduct for Prevention of Insider Trading framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window in respect of dealing in the Equity Shares of the Company for all the Designated Persons of the Company along with their immediate relatives, shall continue to remain closed until 48 hours post declaration of the said financial results. Kindly take the same on your record. Thanking You, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No. A39579